These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24261605)

  • 1. Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study.
    Beauchet O; Launay CP; Allali G; Watfa G; Gallouj K; Herrmann FR; Annweiler C
    BMC Neurol; 2013 Nov; 13():184. PubMed ID: 24261605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.
    Beauchet O; Launay CP; Allali G; Herrmann FR; Annweiler C
    Drugs Aging; 2014 May; 31(5):363-72. PubMed ID: 24683126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial.
    Beauchet O; Barden J; Liu-Ambrose T; Chester VL; Annweiler C; Szturm T; Grenier S; Léonard G; Bherer L; Allali G;
    Drugs Aging; 2016 Sep; 33(9):665-73. PubMed ID: 27568453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis.
    Beauchet O; Launay CP; Allali G; Annweiler C
    CNS Drugs; 2014 Jun; 28(6):513-8. PubMed ID: 24806974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
    Beauchet O; Launay CP; Montero-Odasso M; Annweiler C; Allali G
    Curr Alzheimer Res; 2015; 12(8):761-71. PubMed ID: 26159199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Burns A;
    J Psychopharmacol; 2011 Aug; 25(8):997-1019. PubMed ID: 21088041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective Memory Impairment and Gait Variability in Cognitively Healthy Individuals: Results from a Cross-Sectional Pilot Study.
    Beauchet O; Launay CP; Chabot J; Levinoff EJ; Allali G
    J Alzheimers Dis; 2017; 55(3):965-971. PubMed ID: 27802231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.
    Lopez OL; Becker JT; Wisniewski S; Saxton J; Kaufer DI; DeKosky ST
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):310-4. PubMed ID: 11861686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
    Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study.
    Beauchet O; Launay CP; Sekhon H; Montembeault M; Allali G
    Exp Gerontol; 2019 Jan; 115():55-61. PubMed ID: 30447261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial.
    Annweiler C; Fantino B; Parot-Schinkel E; Thiery S; Gautier J; Beauchet O
    Trials; 2011 Oct; 12():230. PubMed ID: 22014101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.
    Hager K; Baseman AS; Nye JS; Brashear HR; Han J; Sano M; Davis B; Richards HM
    Alzheimers Res Ther; 2016 Nov; 8(1):47. PubMed ID: 27846868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.